Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio J Ansotegui

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
The World Allergy Organization Journal|June 13, 2025
Biologics in IgE-mediated food allergy: A systematic review and meta-analysis of interventional studiesUlugbek B Nurmatov, Lucia Lo Scalzo, Francesca Galletta, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 28, 2023
Doxofylline as a steroid-sparing treatment in Mexican children with asthmaSandra Nora González-Díaz, Ignacio J Ansotegui, Carlos Macouzet-Sánchez, et al.
The World Allergy Organization Journal|May 21, 2026
Toward equitable and evidence-based care in Hereditary Angioedema: Time for inclusive global guidelinesMário Morais-Almeida, Pedro Giavina-Bianchi, Ignacio J Ansotegui, et al.
Journal of Asthma and Allergy|September 23, 2024
Does Comorbid Food Allergy Affect Response to Omalizumab in Patients with Asthma?Alessandro Fiocchi, R Sharon Chinthrajah, Ignacio J Ansotegui, et al.
The World Allergy Organization Journal|July 21, 2025
Artificial intelligence in allergy practice: Digital transformation and the future of clinical careSandra Nora González-Díaz, Mário Morais-Almeida, Ignacio J Ansotegui, et al.
The World Allergy Organization Journal|May 28, 2026
Toward international collaboration in allergy care - WAO White Book on Allergy 2026 - IntroductionMona Al-Ahmad, Ignacio J Ansotegui, Motohiro Ebisawa, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 23, 2022
Correction to: Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochlorideIgnacio J Ansotegui, Jonathan A Bernstein, Giorgio W Canonica, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 13, 2022
Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochlorideIgnacio J Ansotegui, Jonathan A Bernstein, Giorgio W Canonica, et al.
Current Medical Research and Opinion|April 7, 2025
Letter to the editor: author response for "why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review"Ignacio J Ansotegui, Jean Bousquet, Giorgio Walter Canonica, et al.
Current Medical Research and Opinion|July 19, 2024
Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic reviewIgnacio J Ansotegui, Jean Bousquet, Giorgio Walter Canonica, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
The World Allergy Organization Journal|June 13, 2025
Biologics in IgE-mediated food allergy: A systematic review and meta-analysis of interventional studiesUlugbek B Nurmatov, Lucia Lo Scalzo, Francesca Galletta, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 28, 2023
Doxofylline as a steroid-sparing treatment in Mexican children with asthmaSandra Nora González-Díaz, Ignacio J Ansotegui, Carlos Macouzet-Sánchez, et al.
The World Allergy Organization Journal|May 21, 2026
Toward equitable and evidence-based care in Hereditary Angioedema: Time for inclusive global guidelinesMário Morais-Almeida, Pedro Giavina-Bianchi, Ignacio J Ansotegui, et al.
Journal of Asthma and Allergy|September 23, 2024
Does Comorbid Food Allergy Affect Response to Omalizumab in Patients with Asthma?Alessandro Fiocchi, R Sharon Chinthrajah, Ignacio J Ansotegui, et al.
The World Allergy Organization Journal|July 21, 2025
Artificial intelligence in allergy practice: Digital transformation and the future of clinical careSandra Nora González-Díaz, Mário Morais-Almeida, Ignacio J Ansotegui, et al.
The World Allergy Organization Journal|May 28, 2026
Toward international collaboration in allergy care - WAO White Book on Allergy 2026 - IntroductionMona Al-Ahmad, Ignacio J Ansotegui, Motohiro Ebisawa, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|July 23, 2022
Correction to: Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochlorideIgnacio J Ansotegui, Jonathan A Bernstein, Giorgio W Canonica, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|May 13, 2022
Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochlorideIgnacio J Ansotegui, Jonathan A Bernstein, Giorgio W Canonica, et al.
Current Medical Research and Opinion|April 7, 2025
Letter to the editor: author response for "why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review"Ignacio J Ansotegui, Jean Bousquet, Giorgio Walter Canonica, et al.
Current Medical Research and Opinion|July 19, 2024
Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic reviewIgnacio J Ansotegui, Jean Bousquet, Giorgio Walter Canonica, et al.
Pageof 12